Clinical trials
Completed Phase 4 Glucose Intolerance trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carl T. Hayden VA Medical Center | 2 |
| Karolinska Institutet | 2 |
| The University of Texas Health Science Center at San Antonio | 2 |
| University of Oslo School of Pharmacy | 2 |
| Beth Israel Deaconess Medical Center | 1 |
| Charite University, Berlin, Germany | 1 |
| Federico II University | 1 |
| Forest Laboratories | 1 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 1 |
| James J. Peters Veterans Affairs Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Intolerance | 37 |
| Diabetes Mellitus, Type 2 | 10 |
| Insulin Resistance | 9 |
| Hypertension | 5 |
| Obesity | 5 |
| Prediabetic State | 5 |
| Diabetes Mellitus | 4 |
| Hyperglycemia | 2 |
| Metabolic Syndrome | 2 |
| Myocardial Infarction | 2 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.